Poseida surprised market watchers when it decided not to proceed with an IPO last year and instead raised $142 million from backers in a Series C round

Poseida Therapeutics, a company in which Dublin-listed life-sciences investment group Malin has a significant stake, has filed for a potential initial(...)

The company’s proprietary technology can be broadly applied to the more than 30 human protein misfolding diseases

Irish life sciences company Malin has acquired a 33 per cent shareholding of Wren Therapeutics, a newly created biopharmaceutical company based in Cam(...)